Phase 1b/2 study to evaluate eribulin mesylate in...

European Journal of Cancer 2017 / 02 Vol. 72

Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer

Tolaney, S., Savulsky, C., Aktan, G., Xing, D., Almonte, A., Karantza, V., Diab, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
72
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(17)30131-4
Date:
February, 2017
File:
PDF, 52 KB
english, 2017
Conversion to is in progress
Conversion to is failed